Skip to main content
SpringerLink
Log in

Treatment of Portal Systemic Encephalopathy: The Old and New Treatments

  • Chapter
Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 272))

Abstract

Previous chapters have discussed in deep the pathogenesis of hepatic encephalopathies. It is well recognized that portal systemic encephalopathy is a multifactorial syndrome and that, in general, in its chronic recurrent presentation or in acutely precipitated coma, the episode of encephalopathy is reversible unless the precipitating factor per se carries a high degree of mortality (i.e. massive gastrointestinal bleeding, fulminant viral infection, etc) (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Uribe M., Insuficiencia y coma hépatico. En Tratado de Medicina Interna. Uribe M. Editor. Editorial med. Panamericana. Chapter 184 p 1304. Mexico-Buenos Aires 1988.

    Google Scholar 

  2. Hoyos A., Valdovinos MA, Uribe M. Encefalopatia hepatica. Parte II. Tratamiento. Rev Gastroent Mex 1989; 54:35–40.

    Google Scholar 

  3. Uribe M. Dietary management of portal systemic encephalopathy. In Hepatic encephalopathy: management with lactulose and related carbohydrates. H. Conn and J. Bircher Eds. Medi Ed press. East Lansing Michigan. 1989. pp 95–112.

    Google Scholar 

  4. Uribe M., Guevara L., Encephalopatia hepatica. In: Berenguer J Ed. Gastroenterologia y Hepatologia, chapter 51. Barcelona Spain. Ediciones Doyma 1986, 715–723.

    Google Scholar 

  5. Bakti G., Fish HV., Kazlganis G et al . Mechanism of the excessive sedative response of cirrhotics to benzodiazepines. Hepatology 1987; 7:629–638.

    Article  PubMed  CAS  Google Scholar 

  6. Marchesini G., Forlani G., Zoli M. et al .Insulin and glucagon levels in liver cirrhosis. Dig Dis Sci 1979; 24:594–601.

    Article  PubMed  CAS  Google Scholar 

  7. Rikkers L., Jenko P. Rudman D. et al . Subclinical hepatic encephalopathy, detection, prevalence and relationship with nitrogen metabolism. Gastroenterology 1978; 75:462–469.

    PubMed  CAS  Google Scholar 

  8. Uribe M. Marquez MA., Garcia Ramos G et al . Treatment of chronic portal systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Dig Dis Sci 1982; 27:119–126.

    Article  Google Scholar 

  9. Uribe M. Dibildox M., Malpica S. et al . Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus. Gastroenterology 1985; 88:901–906.

    PubMed  CAS  Google Scholar 

  10. Garcia Compean D., Uribe M. Fiber rather than protein determines tolerance to nitrogen load in chronic portal systemic encephalopathy. Hepatology 1987; 7:1034.

    Google Scholar 

  11. Max JL. Amaranthus, A comeback for the food of the Aztecs. Science 1977; 98 4312.

    Google Scholar 

  12. Weber FL., Minco D., Fressard KM. et al . Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects. Gastroenterology 1985; 89:538–544.

    PubMed  CAS  Google Scholar 

  13. Uribe M., Marquez MA., Garcia Ramos G. et al . Treatment of chronic portal systemic encephalopathy with lactose in lactase deficient patients. Dig Dis Sci 1980;; 25:924–929

    Article  PubMed  CAS  Google Scholar 

  14. Pomare EW., Carbohydrate fermentation in the human colon and its relation to acetate concentration in venous blood. J Clin Invest 1985; 74:1448–1454.

    Article  Google Scholar 

  15. Jacobs LR., Lupton JR. Dietary wheat bran lowers colonic pH in rats. J Nutr 1982; 112:592–594.

    PubMed  CAS  Google Scholar 

  16. Reding P., Duchateu J., Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Lancet 1984; 2:493–494.

    Article  PubMed  CAS  Google Scholar 

  17. Uribe M., Campollo O., Vargas F., et al . Acidifying enemas vs. nonacidifying enemas to treat acute portal systemic encephalopathy: a double blind, randomized clinical trial. Hepatology 1987; 7:639–643.

    Article  PubMed  CAS  Google Scholar 

  18. Rossi Fanelli F., Attili A., Cascino A et al ., Vallutazione de 1a eficacia de la tollerabilita del latulossio in forma purificatta nella profilassi e nel trattamento dellencepahlopatia portosistemica. Gaz Med Ita. 1980; 139:267–270.

    Google Scholar 

  19. Uribe M. Toledo H., Perez F. et al . Lactitol a second generation disaccharide for treatment of chronic portal systemic encephalopathy. A double blind crossover, randomized clinical trial. Dig Dis Sci 1987; 32:1345–1353

    Article  PubMed  CAS  Google Scholar 

  20. Uribe M. Moreno Berthier J. Lewis H et al . Lactose enemas plus placebo tablets vs neomycin tablets plus starch enemas in acute portal systemic encephalopathy. A double blind randomized controlled study. Gastroenterology 1981; 81:101–106.

    PubMed  CAS  Google Scholar 

  21. Uribe M., Conn H. Effects of antacids on intestinal response and stool acidification induced by lactulose and lactose in lactose intolerant subjects. Gastroenterology 1982; 82:1248.

    Google Scholar 

  22. Uribe M. Management of portal systemic encephalopathy with lactose. In: Hepatic encephalopathy: Management with lactulose and related carbohydrates. H Conn and J Bircher. Medi Ed press. East Lansing Mich 1989. Chapter 20 pp 283.

    Google Scholar 

  23. Horst D., Grace ND., Conn HO. Comparison of dietary protein with an oral branched chain enriched aminoacid supplement in chronic portal systemic encephalopathy. Hepatology 1984; 4:279–287.

    Article  PubMed  CAS  Google Scholar 

  24. Uribe M., Farca A., Marquez MA., Treatment of chronic portal systemic encephalopathy with bromocriptine. A double blind controlled trial. Gastroenterology 1979; 76:1347–1351

    PubMed  CAS  Google Scholar 

  25. Uribe M. Garcia Ramos G., Ramos MH et al ., Standard and higher doses of bromocriptine for severe chronic portal systemic encephalopathy. Am J Gastroenterology 1983; 517–522.

    Google Scholar 

  26. Schafer DF., Jones EA. Hepatic encephalopathy and the gamma aminobutyric acid neurotransmitter system. Lancet 1982; 1:18–20.

    Article  PubMed  CAS  Google Scholar 

  27. Cooper JL., Erlich ML., Plum F. Hepatic encephalopathy: GABA or ammonia. Lancet 1984; 2:158–159.

    Article  PubMed  CAS  Google Scholar 

  28. Ferenci P. Grimm G., Gangl A., Successful longtime treatment of chronic hepatic encephalopathy with a benzodiazepine antagonist. Hepatology 1987; 7: 1064.

    Google Scholar 

  29. Van der Rijt CCD, Schalm SW., Meulstee J et al . Flumazenil therapy for hepatic encephalopathy: a double blind crossover study. Presented at the annual meeting of the AASLD abs num. 85, 1989.

    Google Scholar 

  30. Bathshaw ML., Brusilow S., Lewis MD. et al Treatment of inborn errors of urea synthesis. NEJM 1982; 306:1387–1392.

    Article  Google Scholar 

  31. Mendenhall CL., Rouster S., Marshall L, A new therapy for portal systemic encephalopathy. Am J Gastroenterology 1986; 81:540–543.

    CAS  Google Scholar 

  32. Uribe M. Gil., Poo JL. Bosques F. Hyperammonemic hepatic encephalopathy treated with sodium benzoate. Final report of a double blind evaluation. Presented at the annual AASLD meeting. Nov 1989.

    Google Scholar 

  33. O’Connor JE., Ribelles M., Grisolia S. Potentiation of hyperammonemia by sodium benzoate in animals: a note of caution. Eur J Pediatr 1982; 138:186–187.

    Article  PubMed  Google Scholar 

  34. O’Connor JE, Costell M, Grisolia S. The potentiation of ammonia toxicity by sodium benzoate is prevented by L-carnitine. Biochem. Biophys. Res Comm 1987; 145:817–824.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto Nacional de la Nutricion and Clinica y Fundación Medica Sur, 14000, D.F, Mexico

    Misael Uribe (Professor of Medicine and Medical Sciences)

Authors
  1. Misael Uribe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Instituto de Investigaciones Citológicas, Caja de Ahorros de Valencia, Valencia, Spain

    Santiago Grisolía , Vicente Felipo  & María-Dolores Miñana ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Press, New York

About this chapter

Cite this chapter

Uribe, M. (1990). Treatment of Portal Systemic Encephalopathy: The Old and New Treatments. In: Grisolía, S., Felipo, V., Miñana, MD. (eds) Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity. Advances in Experimental Medicine and Biology, vol 272. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5826-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5826-8_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5828-2

  • Online ISBN: 978-1-4684-5826-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation